비타민K비의존경구항응고제 사용 후 안정화된 재발뇌경색
A Recurrent Ischemic Stroke Stabilization after Using Non-Vitamin K Antagonist Oral Anticoagulant (NOAC)
1
조회
0
다운로드
0
인용
0
참고문헌
키워드
초록
Current stroke guidelines recommend the administration of non-vitamin-K-antagonist oral anticoagulant (NOAC) for the prevention of cardioembolic stroke induced by nonvalvular atrial fibrillation. We report a patient who suffered from recurrent posterior circulation strokes—occurring eight times in 4 months—even under adequate antiplatelet medication. Changing the medication from antiplatelet agents to NOAC stopped the stroke recurrence. We suggest that NOAC has a role in the prevention of recurrent stroke of undetermined etiology in the posterior circulation.
Abstract
Current stroke guidelines recommend the administration of non-vitamin-K-antagonist oral anticoagulant (NOAC) for the prevention of cardioembolic stroke induced by nonvalvular atrial fibrillation. We report a patient who suffered from recurrent posterior circulation strokes—occurring eight times in 4 months—even under adequate antiplatelet medication. Changing the medication from antiplatelet agents to NOAC stopped the stroke recurrence. We suggest that NOAC has a role in the prevention of recurrent stroke of undetermined etiology in the posterior circulation.
참고문헌 (7)
- Adams RJ, "Update to the AHA", ASA recommendations for the prevention of stroke in patients with stroke and transient ischemic attack, 2008, pp.39, 1647~1652
- Song, SH, "Recurrent posterior circulation infarction caused by anomalous occipital bony process in a young patient", BMC Neurol, 14, pp.252~ (2014)
- Anand SS, "Oral anticoagulant therapy in patients with coronary artery disease: a meta-analysis", JAMA, 282, pp.2058~2067 (1999)
- Mega JL, "Rivaroxaban in patients with a recent acute coronary syndrome", N Engl J Med, 366, pp.9~19 (2012)
- Dressler FA, "Mobile aortic atheroma and systemic emboli: efficacy of anticoagulation and influence of plaque morphology on recurrent stroke", J Am Coll Cardiol, 31, pp.134~138 (1998)
- ESPRIT Study Group, "Medium intensity oral anticoagulants versus aspirin after cerebral ischaemia of arterial origin (ESPRIT): a randomised controlled trial", Lancet Neurol, 6, pp.115~124 (2007)
- Hart RG, "Embolic strokes of undetermined source: the case for a new clinical construct", Lancet Neurol, 13, pp.429~438 (2014)